Cargando…
Development of a CHO cell line for stable production of recombinant antibodies against human MMP9
BACKGROUND: Human matrix metalloproteinase 9 (hMMP9) is a biomarker in several diseases, including cancer, and the need for developing detectors and inhibitors of hMMP9 is increasing. As an antibody against hMMP9 can be selectively bound to hMMP9, the use of anti-MMP9 antibody presents new possibili...
Autores principales: | Ryu, Jina, Kim, Eun-Jung, Kim, Joo-Kyung, Park, Tai Hyun, Kim, Byung-Gee, Jeong, Hee-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903741/ https://www.ncbi.nlm.nih.gov/pubmed/35255869 http://dx.doi.org/10.1186/s12896-022-00738-6 |
Ejemplares similares
-
Generation of a recombinant antibody for sensitive detection of Pseudomonas aeruginosa
por: Lim, Gyu-Min, et al.
Publicado: (2022) -
Generation of Recombinant Antibodies in HEK293F Cells
for the Detection of Staphylococcus aureus
por: Kim, Joo-Kyung, et al.
Publicado: (2022) -
Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line
por: Voronina, E. V., et al.
Publicado: (2016) -
Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β
por: Chen, Weiye, et al.
Publicado: (2011) -
Production of a Soluble Recombinant Antibody Fragment against MMP9 Using Escherichia coli
por: Yeom, Chang-Hun, et al.
Publicado: (2021)